Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Hamilton Health Sciences Corporation

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effect of Caffeine Consumption on Protein Biomarkers and Cardiovascular Disease

Early Phase 1

Not yet recruiting

Conditions: Healthy

Interventions: Drug: Caffeine Pill
Drug: Placebo
Device: TASSO+ Device
Device: Finger prick and collection on Whatman Protein 903 Saver Cards
Device: Intravenous Sampling

First Posted Date: 2024-04-11

Last Posted Date: 2024-04-11

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 36

Registration Number: NCT06359197

Locations: 🇨🇦
David Braley Research Institute, Hamilton, Ontario, Canada
🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada
🇨🇦
McMaster University, Department of Pathology and Molecular Medicine, Hamilton, Ontario, Canada

Postop Pain Management in Pituitary Tumour Patients

Phase 4

Recruiting

Conditions: Pituitary
Pain, Postoperative

Interventions: Drug: Placebo
Drug: Sham Comparator

First Posted Date: 2024-04-09

Last Posted Date: 2025-03-18

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 108

Registration Number: NCT06353529

Locations: 🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada

Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial

Phase 3

Recruiting

Conditions: Surgery
Chronic Kidney Diseases
Acute Kidney Injury
Bleeding

Interventions: Drug: Desmopressin Injectable Solution
Drug: Tranexamic Acid Injectable Product
Other: Placebo

First Posted Date: 2024-03-29

Last Posted Date: 2025-06-13

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 100

Registration Number: NCT06337838

Locations: 🇨🇦
London Health Sciences Centre, London, Ontario, Canada

Inflammation REduction to Prevent CArdiovascular Injury in Renal Disease (REPAIR)

Phase 1

Recruiting

Conditions: Renal Failure
Chronic Kidney Diseases

Interventions: Drug: Colchicine

First Posted Date: 2024-01-12

Last Posted Date: 2025-03-12

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 200

Registration Number: NCT06203977

Locations: 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
🇨🇦
St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada
🇨🇦
London Health Sciences Centre, London, Ontario, Canada

Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy

Phase 2

Recruiting

Conditions: Arrhythmogenic Cardiomyopathy
Arrhythmogenic Right Ventricular Cardiomyopathy

Interventions: Drug: Placebo
Drug: Tideglusib

First Posted Date: 2023-12-18

Last Posted Date: 2025-04-03

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 120

Registration Number: NCT06174220

Locations: 🇨🇦
Foothills Medical Centre, Calgary, Alberta, Canada
🇨🇦
St. Paul's Hospital, Vancouver, British Columbia, Canada
🇨🇦
Victoria Cardiac Arrhythmia Trials Inc., Victoria, British Columbia, Canada

and more 14 locations

Novel Donor Site Dressing (Product X)

Not Applicable

Not yet recruiting

Conditions: Burns

First Posted Date: 2023-12-11

Last Posted Date: 2024-10-02

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 40

Registration Number: NCT06163742

Locations: 🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada

Early Versus Late Upper Extremity Mobilization After Meshed / Sheet Split Thickness Skin Autograft on Wound Healing in Adult Burn Patients

Not Applicable

Not yet recruiting

Conditions: Burns

First Posted Date: 2023-11-22

Last Posted Date: 2023-12-08

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 100

Registration Number: NCT06143683

Infection Prophylaxis in Total Joint Replacement

Phase 3

Recruiting

Conditions: Periprosthetic Joint Infection

Interventions: Other: Saline
Other: Povidone-Iodine
Drug: Vancomycin Hydrochloride
Drug: Chlorhexidine Gluconate

First Posted Date: 2023-11-13

Last Posted Date: 2024-08-21

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 21006

Registration Number: NCT06126614

Locations: 🇨🇦
Hamilton Health Sciences - Juravinski Hospital and Cancer Centre, Hamilton, Ontario, Canada

Chronic Cancer Pain Management Program

Not Applicable

Recruiting

Conditions: Pain Cancer
Breast Cancer
Cancer, Treatment-Related

First Posted Date: 2023-10-26

Last Posted Date: 2024-03-01

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 30

Registration Number: NCT06101849

Locations: 🇨🇦
Juravinski Cancer Centre, Hamilton, Ontario, Canada

Supplementation for Male Subfertility

Phase 2

Not yet recruiting

Conditions: Male Infertility

First Posted Date: 2023-10-23

Last Posted Date: 2024-10-10

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 64

Registration Number: NCT06091969

Locations: 🇨🇦
Mark Tarnopololsky, Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy